BioMall
Brand Store/Clearsynth/N-Boc Deferoxamine-d7
N-Boc Deferoxamine-d7
GENERAL CATALOGUE

N-Boc Deferoxamine-d7

CS-T-96997 ·

Clearsynth · Cat: CS-T-96997

Reach 3+ verified distributors

Manufacturer product page

clearsynth.com/product/CS-T-96997
Catalog No: CS-T-96997
CAS No: -
Category: Deferoxamine
Brand: Clearsynth

Description

NBoc Deferoxamined7 is an intermediate in synthesizing Deferoxamined7 TFA Salt D228982 , a labelled Deferoxamine Mesylate D228980 , which is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients.

More from Clearsynth

Deferoxamine
Deferoxamine
CS-EK-01548
Deferoxamine
Deferoxamine for system suitability(Secondary Standards traceble to EP)
Deferoxamine for system suitability(Secondary Standards traceble to EP)
CS-ER-02709
Deferoxamine
Deferoxamine for peak identification CRS 1(Secondary Standards traceble to EP)
Deferoxamine for peak identification CRS 1(Secondary Standards traceble to EP)
CS-ER-02710
Deferoxamine
N1-Boc O3,O6,O10-Tribenzyl Deferoxamine
N1-Boc O3,O6,O10-Tribenzyl Deferoxamine
CS-T-103255
Deferoxamine
N1-Boc O3,O6,O10-Tribenzyl Deferoxamine-d7
N1-Boc O3,O6,O10-Tribenzyl Deferoxamine-d7
CS-T-96996
Deferoxamine
Deferoxamine Impurity C
Deferoxamine Impurity C
CS-T-103256
Deferoxamine
Deferoxamine for peak identification CRS (Y0001937)
Deferoxamine for peak identification CRS (Y0001937)
CS-EG-03190
Deferoxamine
Deferoxamine for system suitability CRS (Y0001934)
Deferoxamine for system suitability CRS (Y0001934)
CS-EG-03189
Deferoxamine